All case studies

Highlights

We focus our innovation on the factors that matter most — accelerating time to market, reducing costs and enhancing quality. Learn more about how we've helped clients meet and exceed their goals in this selected library of case studies.

Proactive patient retention strategy in a GLP-1 RA trial

Explore how ICON successfully supported a sponsor’s cardiovascular outcome trial for a GLP-1 receptor agonist with 9,900+ patients with type 2 diabetes and maintained a retention rate of 97% over 7 years.

A small biotech success story

A small US-based biotech company was in a race to be the first to market with their lead targeted oncology product.

FSP partnership - sustained efficiency and ongoing innovation

The implementation of an FSP model across our partner's project management function, led to 20% cost efficiences and a 30% reduction in client burden.

By taking a site and patient-centric approach, and leveraging advanced tools and real-time data insights, we maximise patient access, recruitment, and retention—ensuring that every trial is conducted with efficiency, agility, and a commitment to improving patient outcomes.

Case study collections

Our solutions span the entire lifecycle of product development and can be adapted to suit small local trials or large global programs.

Asset Development

Blended Solutions

Cardiac Safety

Clinical & Scientific Operations

Commercial positioning

Decentralised Trials

Early Clinical

Laboratory

Medical Imaging

Real-world intelligence

Regulatory Consulting

Site & Patient Solutions

Asia Pacific

Biotech

Medical Device and Diagnostics

Partnerships

Strategic Solutions

Therapeutics

All case studies

Filter our case studies by categories, selecting amongst our broad range of solutions.

Collaborative approach to advance early phase breast cancer research

A biopharma company partnered with ICON to conduct a phase 1/2 study on breast cancer, overcoming challenges related to regulatory compliance, tight timelines, and data integrity through strategic statistical analysis.

Streamlining non-CDISC decentralised trial data analysis and reporting

A pharma company conducted a phase 2 DCT, and faced challenges with non-standardised data and shifting priorities, which ICON addressed by collaborating with the data vendor to standardize data transfers and using a metadata-driven approach to streamline statistical analysis.

ALS trial best practices ensure success amid recruitment challenges

A pharmaceutical sponsor contracted ICON to run a phase 3 trial for an amyotrophic lateral sclerosis (ALS) treatment that included a large patient population spanning 14 countries.

Accelerating CAR T Study Start-ups

ICON partnered with a top biopharma in the clinical development of CAR T for patients with relapsed and/or refractory Multiple Myeloma (BCMA construct) and B-cell Lymphomas (CD19 construct).

Transformation in a 20-year partnership

Explore the implementation of a dedicated business unit within a 20-year large pharma partnership to facilitate a truly blended solution.

Partnership model evolutions for Top 10 pharma partner

A customised blended model has benefitted a top 10 pharma partner as their organisation has evolved over 13 years.

Chinese sponsor adopts blended delivery model

A Chinese sponsor adopts a blended delivery model to realise cost savings and assume greater autonomy.

Strategic blended solution across multiple services for global upscale

A large pharma partner required a blended solutions to support significant upscale across clinical operations, pharmacovigilance and data science.

Blended solution gives emerging pharma greater control with expert support

When a mid-sized biopharmaceutical company was planning pivotal trials for a drug in a rare disease area, it sought
a more transparent, more reliable operating mode.

In-Home Services: Accelerated patient recruitment

A large pharma company was attempting to recruit 50 patients, including 15 treatment-naive patients, in a global study for a rare pulmonary disorder.

Let's collaborate

Discover how ICON's expertise transforms clinical trials.

Blogs

Stay informed with ICON's expert insights on clinical trials, regulatory changes, and industry trends. Our blogs provide practical advice, innovative solutions, and thought leadership from global experts.

News

Stay updated with our latest news on partnerships, financial results, technological advancements, and industry insights.

Insights

Explore ICON's expert analysis and practical advice on the latest operational, regulatory, technological and economic challenges in clinical research. Our insights provide thought leadership and innovative solutions to transform trials.

Case studies

Highlights

Proactive patient retention strategy in a GLP-1 RA trial

A small biotech success story

FSP partnership - sustained efficiency and ongoing innovation

Case study collections

All case studies

Collaborative approach to advance early phase breast cancer research

Streamlining non-CDISC decentralised trial data analysis and reporting

ALS trial best practices ensure success amid recruitment challenges

Accelerating CAR T Study Start-ups

Transformation in a 20-year partnership

Partnership model evolutions for Top 10 pharma partner

Chinese sponsor adopts blended delivery model

Strategic blended solution across multiple services for global upscale

Blended solution gives emerging pharma greater control with expert support

In-Home Services: Accelerated patient recruitment

Let's collaborate

Blogs

News

Insights